Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Statement re September Factsheet

20 Oct 2015 07:00

RNS Number : 7360C
BlueCrest AllBlue Fund Ltd
20 October 2015
 



FOR IMMEDIATE RELEASE

 

20 October 2015

 

BLUECREST ALLBLUE FUND LIMITED

FACTSHEET - SEPTEMBER 2015

"A solid performance against difficult markets"

 

BlueCrest AllBlue Fund Limited (BCAB) rose by 0.3% in September, a solid performance against a backdrop of difficult markets, bringing the gain for the year to date to 2.9% (Sterling Class NAV). The rolling 12 month return remained level at 3.8% and volatility was stable, at 3.2%.

 

Markets were nervous and choppy as economic data remained generally disappointing, particularly from China. Emerging markets continued to feel the strain and the MSCI Emerging Markets index finished September down 17% on a year to date basis. Credit markets also suffered and exhibited some illiquidity, particularly in high yield. The US Federal Reserve keeping rates unchanged did nothing to settle investors' stomachs.

 

"Strongest performance came from BlueTrend 2x"

 

As in August, five of the seven underlying strategies generated positive performance. BlueCrest Multi Strategy Credit and BlueCrest Quantitative Equity detracted once again, albeit only modestly.

 

The strongest performance came from BlueTrend 2x, which rose by over 4.5% on the month. Although only three of BlueTrend's seven strategies produced positive performance, the four detracting strategies did little to dent to strong gains coming from long positioning in bonds, an orientation which was maintained by the model for the entire month. Strong performance was also seen from the short term interest rates sector. Positioning in equities and commodities was maintained net short. Overall risk levels increased slightly during the month.

 

Despite the turmoil in emerging markets, BlueCrest Emerging Markets Fund eked out a small gain. BlueCrest Multi Strategy Credit was the worst performing fund in September at -0.6% on the month. Gains were seen in volatility trading and convertible bond arbitrage with losses in long/short strategies. High yield positioning was largely flat despite illiquidity in the cash bond market seeing some sharp price falls. The risk exposure in the fund was already defensive entering September and there were further modest tactical risk reductions during the month.

 

BlueCrest Mercantile produced a small positive return as both the Trade Credit Opportunities and Bank Basel III strategies were positive. The former saw the Ukrainian sovereign CDS hedges triggered by default but the underlying trade finance positions pay out in full. The Bank Basel III strategy produced the majority of returns as emerging market mark-downs were offset by CDS hedge protection. Small losses were seen from some mining positions. A good pipeline of securitisations is being seen which are expected to become available by year end.

 

A small increase of 1.5% was made to the allocation to BlueCrest Equity Strategies for October at the expense of BlueTrend 2x and BlueCrest Capital International.

 

"The Company continued its buyback"

 

The Company continued its buyback activity during September, although selling pressure has subsequently abated. The discount remains reasonably stable, either side of 5%.

Disclaimer:

This document is directed only at: (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005; or (ii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and persons who receive this document who do not fall within (i) or (ii) above should not rely on or act upon this document.

 

This document is issued by BlueCrest AllBlue Fund Limited (the "Company") to and for the information of its existing shareholders and does not in any jurisdiction constitute investment advice or an invitation to invest in the shares or any other securities of the Company or any other entity (body corporate or otherwise).

 

The Company has used reasonable care to ensure that the information included in this document is accurate at the date of its issue, but does not undertake to update or revise the information, including any information relating to AllBlue Limited and its underlying funds (the "Funds") provided by BlueCrest Capital Management (UK) LLP or any member of the BlueCrest group of companies (as applicable) ("BlueCrest"), or guarantee the accuracy of such information. To the extent permitted by law neither the Company, the Funds, BlueCrest nor their directors or officers shall be liable for any loss or damage that anyone may suffer in reliance on such information.

 

The information in this document may be changed by the Company at any time. Past performance cannot be relied on as a guide to future performance. The Company's investment strategy is speculative and entails substantial risks. The value of an investment may go down as well as up and some or all of the total amount invested may be lost. This document may not, in whole or in part, directly or indirectly, be taken, transmitted or distributed into the United States of America, its territories or possessions or made available to any national, resident or citizen of the United States of America or any other jurisdiction where applicable laws prohibit its release, distribution or publication. Any failure to comply with these restrictions may be a violation of the law in relevant jurisdictions.

 

JTC (Guernsey) Limited

Secretary

 

Tel: Guernsey 01481 702400

 

END OF ANNOUNCEMENT

E&OE - in transmission

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUKAVRVAARAAA
Date   Source Headline
17th Sep 20195:20 pmRNSResult of Extraordinary General Meeting
17th Sep 20191:46 pmRNSNet Asset Value(s) - Weekly Estimate
17th Sep 201911:39 amRNSHolding(s) in Company
13th Sep 20197:00 amRNSHalf-year Report
12th Sep 201910:24 amRNSProposed Investment by JPMorgan Asset Management
11th Sep 20194:52 pmRNSNet Asset Value(s) - Weekly Estimate
11th Sep 20194:14 pmRNSHolding(s) in Company
9th Sep 20192:37 pmRNSHolding(s) in Company
9th Sep 201912:04 pmRNSNet Asset Value(s) - Weekly Estimate
2nd Sep 201911:25 amRNSTotal Voting Rights
29th Aug 201911:35 amRNSHolding(s) in Company
29th Aug 201910:16 amRNSNet Asset Value(s) - Weekly Estimate
28th Aug 20195:20 pmRNSHolding(s) in Company
28th Aug 20193:37 pmRNSPublication of Circular
27th Aug 20195:01 pmRNSNet Asset Value(s) - Final
22nd Aug 20199:26 amRNSHolding(s) in Company
21st Aug 20195:17 pmRNSNet Asset Value(s) - Weekly Estimate
21st Aug 201910:19 amRNSHolding(s) in Company
20th Aug 20194:32 pmRNSHolding(s) in Company
20th Aug 20194:07 pmRNSHolding(s) in Company
16th Aug 20195:22 pmRNSResult of EGM, Redemptions and Revised Proposals
13th Aug 20195:18 pmRNSNet Asset Value(s) - Weekly Estimate
12th Aug 201911:02 amRNSHolding(s) in Company
8th Aug 20192:55 pmRNSHolding(s) in Company
7th Aug 20192:53 pmRNSHolding(s) in Company
7th Aug 201910:15 amRNSHolding(s) in Company
5th Aug 20194:43 pmRNSNet Asset Value(s) - Weekly Estimate
2nd Aug 20192:16 pmRNSResult of AGM
31st Jul 20194:33 pmRNSPublication of Circular and Notice of EGM
31st Jul 20192:58 pmRNSNet Asset Value(s) - Weekly Estimate
29th Jul 20195:18 pmRNSConfirmation of AllBlue Proceeds Received
26th Jul 201912:29 pmRNSNet Asset Value(s) - Final
25th Jul 20194:08 pmRNSNet Asset Value(s) - Weekly Estimate
19th Jul 20193:00 pmRNSHolding(s) in Company
17th Jul 20194:02 pmRNSNet Asset Value(s) - Weekly Estimate
9th Jul 20193:47 pmRNSNet Asset Value(s) - Weekly Estimate
8th Jul 20197:00 amRNSCompany Update
4th Jul 20194:52 pmRNSNet Asset Value(s) - Weekly Estimate
2nd Jul 20192:31 pmRNSHolding(s) in Company
1st Jul 20197:00 amRNSTotal Voting Rights
27th Jun 20193:53 pmRNSNet Asset Value(s) - Final
25th Jun 20195:04 pmRNSNet Asset Value - Weekly Estimate
25th Jun 20193:23 pmRNSExtension of Election Deadline
19th Jun 20194:54 pmRNSNet Asset Value(s)
17th Jun 20196:05 pmRNSNotification from Manager
17th Jun 20195:15 pmRNSTransaction in Own Shares
11th Jun 20195:02 pmRNSTransaction in Own Shares
11th Jun 20194:05 pmRNSNet Asset Value(s)
7th Jun 20195:17 pmRNSTransaction in Own Shares
6th Jun 20194:54 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.